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Abstract

Non-medical use of prescription drugs (NMUPD) by adolescents is a significant public
health concern. The present study investigated whether NMUPD is associated with future
delinquency using baseline, 6-month, and 12-month follow-up data of 1,349 adolescent offenders
from the Pathways to Desistance project. Results indicated baseline differences across three
NMUPD use groups on demographic factors, violence exposure, mental health diagnoses, other
drug use, and previous delinquency, suggesting that severity of NMUPD is important to
consider. Further, NMUPD significantly predicted drug-related, non-aggressive, and aggressive
delinquency 12 months later even after considering other known correlates of delinquency.
Analyses suggest that NMUPD contributes to future delinquency in part because NMUPD users
are exposed to violence, have enduring mental health and drug use problems, and have
delinquency histories. These findings suggest that NMUPD is an important component of future
delinquency for adolescent offenders but it should be considered within the context of other
known risk factors.
Keywords: prescription drugs, adolescence, offenders, substance abuse, delinquency
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1. Introduction
Over the last two decades opioids and other psychotherapeutic medications, such as
tranquilizers, stimulants, and sedatives have been prescribed in greater frequency in the United
States, especially to adolescents and young adults (Fortuna, Robbins, Caiola, Joynt, &
Halterman, 2010; Thomas, Conrad, Casler, & Goodman, 2006). Coupled with a corresponding
increase in the non-medical use and abuse of those drugs, this has been topic of controversy and
reason for great concern (Ford, 2008; Manchikanti & Singh, 2008; Novak, Calvin, Glasheen, &
Edlund, 2011; Thomas et al., 2006; Young, Glover, & Havens, 2012).
The National Survey on Drug Use and Health (NSDUH) defines non-medical use of
prescription drugs (NMUPD) as use of at least one psychotherapeutic drug from four categories
of prescription-type drugs (i.e., opioids, tranquilizers, stimulants, and sedatives) “without a
prescription of the individual's own or simply for the experience or feeling the drugs caused”
(Substance Abuse and Mental Health Services Administration (SAMHSA), 2013b). National
estimates of substance use in the general population show that the use of non-medical
prescription drugs has become more prevalent than the use of other illicit drugs with the
exception of marijuana; 2.4 million Americans engaged in NMUPD for the first time within the
past year in 2012, an average of 6,700 initiates per day (SAMHSA, 2013b). This is a significant
public health concern: prescription opioid abuse alone was estimated to cost the U.S. $55.7
billion in 2007 (Birnbaum et al., 2011).
1.1. Adolescent Substance Use, Delinquency and NMUPD
As with other forms of substance use, findings indicate that adolescents and young adults
are at the greatest risk of NMUPD relative to other age groups (Novak, Calvin, Glasheen, &
Edlund, 2011; SAMHSA, 2006, 2013b), and numerous studies have explored NMUPD among
adolescents (Ford, 2008; Johnston, O’Malley, Bachman, & Schulenberg, 2011; Young et al.,
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2012). NMUPD was the second most popular illicit drug for adolescents after marijuana in a
nationally representative community sample, with a peak of 4.0 % past month users among 16
and 17 year olds in the 2013 NSDUH. This finding extended to 12 to 13 year olds: NMUPD was
the most prevalent illicit drug used, with 1.7 % reporting past month use (SAMHSA, 2013b). In
2009, the NSDUH showed that among all past year adolescent users about 16% met the criteria
for abuse or dependence, indicating that problematic levels of abuse are developing far earlier in
life course compared to other illicit drugs such as cocaine or heroin, where the median age of
abuse and dependence is situated in the mid-20s (Novak et al., 2011).
Beyond abuse and dependence, studies investigating life experiences and mental health
symptoms have found that trauma, a history of significant witnessed violence, post-traumatic
stress disorder (PTSD), and major depressive disorder (MDD) were associated with adolescent
NMUPD use (Catalano, White, Fleming, & Haggerty, 2011; McCauley et al., 2010; Schepis &
Krishnan-Sarin, 2008). Further, NMUPD use has been linked with poor school performance and
lower school bonding (Ford, 2009; Schepis & Krishnan-Sarin, 2008) and delinquency (Ford,
2008). Overall, NMUPD users are at an increased risk for emergency room visits (SAMHSA,
2013a) and death (Centers for Disease Control and Prevention (CDC), 2012; Paulozzi et al.,
2012). Youth who engage in NMUPD are significantly more likely than their peers to use other
illicit drugs and to combine prescription drugs with alcohol and other substances. These practices
not only further increase the risk of involvement with the juvenile justice system, they also lead
to increased risk for potentially dangerous drug interactions and their negative outcomes (Garnier
et al., 2009; McCabe, Teter, & Boyd, 2006).
Clearly, NMUPD among juveniles is a large public health problem with significant
consequences, yet studies investigating NMUPD in adolescent samples indicate that there is
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considerable variation in both prevalence of NMUPD and demographic, behavioral, and social
correlates (Boyd, Young, Grey, & McCabe, 2009; Young et al., 2012). For example, in general
NMUPD has been lower among racially and ethnically non-White adolescents compared to their
White counterparts (McCabe, West, Teter, & Boyd, 2012; McCauley et al., 2010; SAMHSA,
2013b). Overall prevalence rates and trends in high risk samples of adolescents are missing from
the literature.
Adolescents are more likely than young adults to use multiple drugs, and a plethora of
evidence suggests that there is a substantial overlap in NMUPD and the use of marijuana and
other illicit drugs (Boyd, Young, Grey, & McCabe, 2009; Catalano et al., 2011; Ford, 2008;
McCabe et al., 2012; Schepis & Krishnan-Sarin, 2008; SAMHSA, 2013b; Wu, Schlenger, &
Galvin, 2006; Young et al., 2012). Several researchers have thus suggested that NMUPD might
simply be another form of illicit substance use, and that negative consequences of NMUPD
might overlap with symptoms of polydrug use (Catalano et al., 2011; Ford, 2008; Young et al.,
2012). Possible explanations of the relationship between illicit substance use, alcohol, and
NMUPD is that an adolescent who already is abusing substances might share some of the risk
factors associated with NMUPD; he or she might already know where and how to access
prescription drugs and receive less parental monitoring compared to non-using peers.
Additionally, adolescents who binge drink, abuse alcohol, or use other illicit drugs may engage
in NMUPD for similar affective reasons – either an attempt to numb affect or experience
excitement (McCauley et al., 2010). There is some support for this hypothesis in data linking
NMUPD to delinquency, with one study of students finding that NMUPD motivated by thrillseeking, but not motivated by self-treatment, was connected to both other illicit drug use and
delinquency (Boyd et al., 2009).
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A wealth of research documents the association between illicit drug use and increased
risk of general and aggressive delinquency among adolescents (Adams et al., 2013; Barnes,
Welte, & Hoffman, 2002; Doran, Luczak, Bekman, Koutsenok, & Brown, 2012; Ford, 2008;
Mason & Windle, 2002). Substance use has been associated with continuity in offending,
decreased likelihood of desistance, and increased risk of reoffending; it also distinguished high
level chronic offenders from less severe offender groups (Mulvey, Schubert, & Chassin, 2010;
Schubert, Mulvey, & Glasheen, 2011). While comparatively more limited than the general
literature, there is some evidence that links NMUPD specifically with delinquency in adolescents
(Adams et al., 2013; Boyd et al., 2009; Catalano et al., 2011; Sung, Richter, Vaughan, Johnson,
& Thom, 2005). One of the few studies focusing on NMUPD and delinquency is Ford’s (2008)
analysis of the connection between NMUPD and delinquency in the community sample of the
2005 NSDUH. In this study, results indicated that NMUPD overall, as well as specific categories
of drugs (i.e., opioids, tranquilizers stimulants, and sedatives), were significantly associated with
self-reported general delinquency in adolescents. Further, overall NMUPD and the non-medical
use of opioids were associated with increased likelihood of arrest among 12 to 17 year old
adolescents. The study found that in this sample, the use of other illicit drugs (not including
marijuana) was more strongly associated with self-reported general delinquency and arrest than
NMUPD. However, severity of drug use and use of marijuana were not included in the analyses
and differential relationships of NMUPD to aggressive versus non-aggressive or drug-related
delinquency were not investigated.
Evidence regarding differential relationships of illicit drug use, alcohol use, and different
types of delinquency is comparatively more equivocal than the relationship to general
delinquency. Data from the most recent NSDUH shows that youths aged 12 to 17 who had
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engaged in fighting or other delinquent behaviors in the past year were more likely than other
youths to have used illicit drugs in the past month (SAMHSA, 2013b).These findings suggest
that among adolescents in the community, illicit drug use compared with NMUPD is more
directly associated with non-violent property-related crime. In contrast however, a wealth of
research has shown that substance use confers an increased risk for aggression (versus general
delinquency), with early use a particularly strong predictor of violent behavior (Doran et al.,
2012; Hawkins et al., 2000; Martel et al., 2009). Relationships between NMUPD and different
delinquent behaviors have not yet been assessed, even though there is some evidence of potential
differences in the association of NMUPD and different forms of delinquency. One longitudinal
study found that the non-medical use of prescription opioids among adolescents was associated
with violent behavior, but explained little variance in property crime (Catalano et al., 2011), and,
as stated above, a study with high-school students found that only NMUPD motivated by
sensation seeking, and not self-treatment, was associated with delinquency (Boyd et al., 2009).
However, in a sample of justice system-involved, high-risk youth, substance use was equally
related to drug-related, interpersonal, and property delinquency with stability over time
(D’Amico, Edelen, Miles, & Morral, 2008).
1.2. Substance Use and NMUPD among Juvenile Offenders
The increased prevalence of mental health problems and substance use disorders together
with an elevated rate of substance use among juvenile offenders in the juvenile justice system is
a well-known issue (Chassin, 2008; Shook, Vaughn, Goodkind, & Johnson, 2011; Vaughn,
Freedenthal, Jenson, & Howard, 2007; Vaughn, Howard, Foster, Dayton, & Zelner, 2005). As
mentioned above, substance use disorders are linked to continued offending and violence in
community and offender samples of adolescents (Adams et al., 2013; Chassin, 2008; Mulvey et
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al., 2004a). Among juvenile offenders, the presence of a substance use disorder is consistently
associated with more re-arrests, more self-reported antisocial activity, more drug-related,
interpersonal, and property delinquency, and less engagement in gainful activity, both crosssectionally and over time (D’Amico et al., 2008; Mulvey et al., 2004a; Schubert et al., 2011).
Our knowledge of prevalence and correlates of NMUPD among this high-risk population
is limited to a few studies examining correlates of mostly binary lifetime NMUPD in currently
incarcerated samples. One of the few studies taking into account the severity of drug use in this
population examined patterns of illicit drug use and mental health concerns among a state
population of 723 incarcerated juvenile offenders and found that level of lifetime poly-substance
use and severity of problems stemming from alcohol and drug use were associated with severity
of mental health symptoms, including past traumatic experiences (Vaughn et al., 2007). Links
between drug use and delinquency or NMUPD specifically were not assessed. The only study
examining the correlates of NMUPD in a sample of confined adolescents was conducted with the
population of one urban detention center in Ohio (Alemagno, Stephens, Shaffer-King, &
Teasdale, 2009). It showed that overall 10% of incarcerated male youth reported lifetime
NMUPD. Arrestees reporting NMUPD had higher levels of overall other illicit drug use, more
alcohol problems, reported more trauma and problems with anger management, as well as more
risky sexual behaviors. However, frequency or recency of NMUPD use as well as any relation to
non-aggressive or drug-related delinquency was not reported. Finally, there was one study with
227 incarcerated juveniles comparing youthful offenders who sold drugs with those who did not
sell drugs on substance use and other behaviors (Shook et al., 2011). Results suggested that
juveniles engaging in either selling marijuana or hard drugs were using marijuana use, other
illicit drugs, and NMUPD at substantially elevated rates, suggesting a significant overlap
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between own substance use and dealing of drugs. In summary, there is sparse knowledge about
NMUPD use specifically among adolescent offenders. Given the high prevalence of substance
use, mental health issues and thrill-seeking behaviors in offenders, they are at increased risk for
the NMUPD. Given national trends in NMUPD it seems especially important to understand the
unique contribution of NMUPD to future patterns of delinquency and other substance use.
Investigating whether NMUPD uniquely contributes to patterns of recidivism has potentially
important implications for treatment of substance use problems and targeted prevention efforts in
this population.
1.3. Current Study
The present study contributes to the literature in several ways. Serious adolescent
offenders are a group with an especially elevated risk of engaging in both substance use and
continued delinquency. While there is some evidence that NMUPD is associated with
delinquency in community samples, limited data on the characteristics of NMUPD users among
serious adolescent offenders exists. Additionally, the existing knowledge about NMUPD use
among offenders largely stems from incarcerated samples reporting on past behavior; there is a
dearth of longitudinal research that investigates how NMUPD influences delinquency over time
above and beyond known correlates of delinquency. The present study describes and compares
serious juvenile offenders who have never engaged in NMUPD, engaged in NMUPD only
experimentally or long ago, and recent frequent users. Further, the present study investigates the
relationship between NMUPD and different forms of delinquency; there are no studies to date
that investigate the influence of NMUPD on drug-related, non-aggressive, and aggressive
delinquency separately. Finally, the present study investigates these relationships longitudinally
and investigates NMUPD influences on different types of future delinquency above and beyond
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other known correlates of delinquency, closing a substantial gap in knowledge, and providing
data that can inform prevention and treatment of this high-risk group of adolescent offenders.
Thus, the purposes of the current study were to investigate two research questions: (1)
What is the profile of NMUPD among serious juvenile offenders? and (2) What is the unique
contribution of NMUPD in predicting future drug-related, non-aggressive, and aggressive
delinquency among serious adolescent offenders beyond known correlates of delinquency?
2. Materials and methods
2.1. Participants
The present article is a secondary data analysis from the Pathways to Desistance project,
a multisite, longitudinal study of serious juvenile offenders (Mulvey et al., 2004b). Beginning in
2000, project staff recruited 1,354 adolescents aged 14 through 17 who were adjudicated
delinquent, or found guilty of a serious (overwhelmingly felony-level) offense, at their current
court appearance in Philadelphia, PA (N = 654) and Phoenix, AZ (N = 700). The number of
males adjudicated for a drug offense was capped at 15% of the sample so as to avoid
overrepresentation of drug offenders. All females and all youth transferred to the adult system
who met the enrollment criteria also were recruited to participate.
Immediately after enrollment, researchers conducted a structured 4-hour baseline
interview with each adolescent. The interview included a thorough assessment of the youth’s
social background, developmental history, psychological functioning, psychosocial maturity,
attitudes about illegal behavior, intelligence, school achievement and engagement, work
experience, mental health, current and previous substance use and abuse, family and peer
relationships, use of social services, and antisocial behavior. After the baseline interview,
researchers interviewed participants every six months for the three years and annually thereafter.
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At each follow-up interview, researchers gathered information on the adolescent’s self-reported
behavior and experiences during the prior 6 months, including any illegal activity, drug or
alcohol use, and involvement with treatment or other services. In addition, the follow-up
interviews collected data on changes in life situations (e.g., living arrangements and
employment), developmental factors (e.g., likelihood of thinking about and planning for the
future and relationships with parents), and functional capacities (e.g., mental health symptoms).
The current study uses data from the baseline, 6-month follow-up and 12-month follow-up
interviews only (retention rates = 93% of the full sample). Additional details regarding the study
rationale can be found in Mulvey and colleagues (2004), and additional details regarding the
study design, sample, and methodology are in Schubert and colleagues (2004).
Five participants were missing data on NMUPD and therefore were not included in our
analyses (N = 1,349). The majority of the selected sample was male (86%, n = 1,165). The
race/ethnicity of the sample was 41% Black, 34% Hispanic, 20% White, and 5% other. The
participants’ average age was 16.04 years (SD = 1.14 years). The most common family structure
was a youth with their biological mother who was single and never married (21%), followed by
biological mother and step-father (18%), biological mother who was single and divorced or
separated (16%), two biological parents (15%), other adult relative (12%), no adult in home
(5%), and other (13%).
2.2. Measures
2.2.1. Demographics. A single item represented race/ethnicity (i.e., White, Black,
Hispanic, Other), and a single item assessed gender (1 = male, 2 = female); age in years was a
continuous variable.
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Socioeconomic status (SES) was based on both parental education and occupation.
Reported parental occupation and education were coded using a seven-point scale ranging from 1
(higher executives, proprietors, major professionals; professional degree) to 7 (unskilled
employees; less than seven years of school) based on Hollingshead's index of social position (see
Hollingshead, 1957). Then, a parental Index of Social Position (ISP) which is based on the
formula ((Occupation score x 7) + (Education score x 4)) was computed (see Hollingshead,
1970). When both the occupation and education for the parent was unknown, the individual
parent ISP score was not computed. If only one of the two components was known, the missing
information was derived using the available data. The mean of the mother and father occupation
and education was taken when data for both parents were available.
Proportion of time spent in facilities with no community access was also assessed at the
6-month and 12-month follow-up interviews. This value was a proportion indicating the total
days during the recall period that the participant was reported to be in a facility with no
community access. The average of the proportion from the two time points was used in the
current study.
2.2.2. Violence exposure. The Exposure to Violence Inventory (ETV; Selner-O’Hagan,
Kindlon, Buka, Raudenbush, & Earls, 1998) was modified for this study to assess the frequency
of exposure to violent events. Items document the types of violence the adolescent both
experienced (i.e., Victim - 6 items, e.g., ‘‘Have you ever been chased where you thought you
might be seriously hurt?’’) and observed (i.e., Witnessed - 7 items, e.g., ‘‘Have you ever seen
someone else being raped, an attempt made to rape someone or any other type of sexual
attack?’’). A total score was created that summed the victim and witness items that were
endorsed. Higher scores indicate greater exposure to violence.
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2.2.3. Mental health. The Composite International Diagnostic Interview (CIDI; World
Health Organization, 1990) is a comprehensive, fully structured interview used to assess mental
disorders. By means of computerized algorithms, the CIDI provides both lifetime ("Ever") and
current ("Past year" and "Past 30 days") diagnosis as defined by the DSM-IV and ICD-10. The
entire CIDI was not administered and the following six modules were selected for the purpose of
the current study: major depressive disorder (MDD), posttraumatic stress disorder (PTSD),
alcohol abuse, alcohol dependence, drug abuse, and drug dependence. During the interview, all
participants were asked questions about selective symptoms of psychiatric disorders. Based on
predetermined skip patterns, positive responses to these screening items were followed by more
detailed questions to determine if the endorsed symptom is a psychiatric symptom and is not due
to medication, drugs, alcohol, or to a physical illness or injury. If symptoms were endorsed and
occurred in a pattern which suggested a diagnosis might be present, additional questions were
asked to establish the onset and recency of the symptoms. Participants were either given a
diagnosis or not for lifetime, past year, and past 30 days on all selected diagnoses. Additionally,
a severity scale was calculated. For each disorder participants were coded either “0 – Never had
diagnosis,” “1 – Had diagnosis in lifetime,” “2 – Had diagnosis in past year,” or “3 – Had
diagnosis in past 30 days.” Higher scores indicated a more frequent diagnosis.
2.2.4. Drug use. A modified version of The Substance Use/Abuse Inventory, developed
by Chassin, Rogosch, and Barrera (1991) for use in a study of children of alcoholics was used to
assess adolescent's self-reported use of illegal drugs and alcohol over the course of his/her
lifetime and in the past 6-months (e.g., "How often have you had alcohol to drink?"). The current
study only used the Substance Use subscale to measure use of alcohol, marijuana, and other
illicit drugs (i.e., cocaine, opioids, ecstasy, hallucinogens). Additionally, youth were asked
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whether they have used sedatives (e.g., sleeping pills, barbiturates, seconal, valium, librium,
xanax, qualludes, etc.) or stimulants (e.g., diet pills, benzadrine, methamphetamine) to get high,
and if so how frequently (0 = Not at all to 9 = Everyday). These questions were used to assess
NMUPD.
2.2.5. Delinquency history. A modified version of the Self-Report of Offending (SRO;
Elliott, 1990; Huizinga, Esbensen, & Weiher, 1991) scale was used at each interview to measure
the adolescent’s account of his/her involvement in three drug-related delinquent acts (i.e., selling
marijuana, selling other illegal drugs, driving while intoxicated or high), six non-aggressive
delinquent acts (i.e., breaking in to steal, shoplifting, buying/receiving/selling stolen property,
using checks or credit cards illegally, stealing a car or motorcycle, carjacking, being paid by
someone for sex), and 11 different aggressive delinquent acts (i.e., destroying/damaging
property, setting fires, forcing someone to have sex, killing someone, shooting at someone
(bullet hit or did not hit), robbery with weapon, robbery without weapon, assault, fights, fights as
part of gang activity). For each endorsed item at baseline, the follow-up question "How many
times have you done this in the past year?" was asked. This item was used to identify whether the
adolescent reported doing an act within the past six months. At the follow-up interviews the
participants were again asked if they engaged in any of these activities since the last interview. A
sum of the number of items endorsed was divided by the number of questions answered to
produce a ‘‘general variety’’ proportion score (range 0 to 1) for each participant for drug-related,
non-aggressive, and aggressive delinquency. This score assessed the number of different types of
delinquent acts in which the participant engaged and was used in the current study as a severity
index for delinquency. Higher scores indicate more varied, and hence severe, delinquency
patterns.
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2.3. Data analysis
Analyses were performed using SPSS Version 21 (IBM Corp., 2012). Three mutually
exclusive groups were created to assess frequency and current NMUPD at baseline. The first
group consisted of youth who reported no NMUPD (i.e., no NMUPD of either stimulants or
sedatives); the second group comprised youth who had engaged in NMUPD but less than at least
once a month in the past six months; youth in the third group reported NMUPD at least once a
month in the past six months. Then, univariate tests of differences between the three groups on
demographic, violence exposure, mental health, other drug use, and delinquency history
variables were tested either with 2 (for categorical variables) or one-way analysis of variance
(ANOVA; for continuous variables). In these analyses race/ethnicity was dichotomized (1 =
White, 0 = all others).
Next, to assess future delinquency across the following 12 months from baseline, the
average variety proportion score was calculated from the 6-month and 12-month follow-ups for
each area of delinquency: drug-related, non-aggressive, and aggressive. The mean of the reported
offending history proportion score was used to capture the variety of delinquency from baseline
to 6-months and then from 6-months to 12-months.
Then, a series of six analyses of covariance (ANCOVAs) models predicting delinquency
across 12 months were estimated separately for drug-related delinquency, non-aggressive
delinquency, and aggressive delinquency. Each type of delinquency was studied separately as
previous research has suggested that what predicts one type of delinquency may be different
from what predicts other types of delinquency (Catalano et al., 2011). Also, each set of
covariates was grouped and analyzed separately to determine the relative importance of NMUPD
within each domain. The demographic model included race/ethnicity, sex, age, and SES as
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covariates. Additionally, to account for the effect of institutional confinement on the adolescent’s
level of delinquency (Piquero et al., 2001), proportion of time with no community access was
added as an additional covariate in the analyses. All of the following models included the
demographic variables and a unique set of covariates known to also be involved in future
delinquency; the covariates were not continually added from one model to the next. The second
model added total violence exposure as a covariate to the demographic variables. The third
model, the mental health model, added the severity scores for MDD, PTSD, alcohol abuse,
alcohol dependency, drug abuse, and drug dependency as covariates to the demographic
variables. The fourth model added the youth’s lifetime use of alcohol, marijuana, and illicit drugs
as covariates; while the fifth model added the youth’s lifetime history of drug-related
delinquency, non-aggressive delinquency, and aggressive delinquency to the demographic
covariates. The sixth, and final model, included all the significant covariates from previous
analyses in the model and the demographic variables. Planned contrast tests were then conducted
to determine the specific group differences when the F-statistic was significant. All analyses
utilizing continuous variables used Bonferonni correction to adjust for multiple comparisons.
3. Results
3.1. Missing Data Analysis
A missing data analysis was conducted on all independent variables and the missing data
was found to be missing completely at random (MCAR) according to Little’s chi-square statistic
(Little, 1988), 2 = 425.53, df = 405, p = .23.
3.2. Baseline Differences Based on NMUPD User Group
Table 1 reports the findings from the 2 and ANOVA tests assessing baseline differences
in demographics and known correlates of delinquency (i.e., violence exposure, mental health,
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other drug use, delinquency history) across patterns of NMUPD. There were significant group
differences on all measures except SES and proportion of time spent with no community access.
Black participants were overrepresented in the “never used NMUPD” group, whereas Hispanics
were overrepresented in the “used NMUPD at least once in a lifetime” group. Whites and
Hispanics were equally overrepresented in the “current NMUPD user” category. Additionally,
NMUPD users compared to non-users were significantly older, although there were no
differences between NMUPD at least once in lifetime and current NMUPD users. Proportionally
more females reported NMUPD use than non-use; this was particularly evident in the current
NMUPD use category.
In reference to violence exposure, a linear trend was evident at baseline with more
violence exposure being reported with more NMUPD. All three groups of NMUPD users were
significantly different from one another on direct victimization and total violence exposure. For
witnessed violence, youth who never used NMUPD witnessed less violence than both other
groups of NMUPD users, who were not different from one another.
Similarly, there were baseline NMUPD group differences in all mental health categories.
With one exception, these differences were linear: youth with no NMUPD had a lower
proportion of lifetime, past year, and past 30 days mental health diagnoses compared with youth
who had used prescription drugs non-medically but not recently; those youth in turn had a lower
proportion of diagnoses than youth who were current NMUPD users. The one exception was for
past 30 days alcohol dependency. In that case more mental health diagnoses were found in the
used NMUPD at least once in lifetime as compared to current NMUPD users.
There also were significant differences at baseline between all three NMUPD groups in
their lifetime and past 6-month use of alcohol, marijuana, and illicit drugs. The only exception
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was lifetime marijuana use, where youth who never used NMUPD reported lower lifetime use
than both other groups, who were not different from one another.
Finally, there were baseline differences between the three NMUPD groups on lifetime
and past 6 month delinquency. As NMUPD use became more frequent and recent, lifetime and
past 6 month drug-related, non-aggressive, and aggressive delinquent acts increased. The one
exception was that for drug-related offenses in the past 6 months the differences were between
current NMUPD users and the other two groups.
[INSERT TABLE 1 ABOUT HERE]
3.3. ANCOVAs for NMUPD Predicting Future Delinquency
3.3.1. Drug-related delinquency. NMUPD group membership significantly predicted
future drug-related delinquency in the demographic, violence exposure, other drug use, and
delinquency history models. In each of these models, NMUPD group membership explained
more variance in future drug-related delinquency than the covariates (2p ranged from .03 to
.01), except the delinquency history model. In the delinquency history model, previous drugrelated delinquency was the strongest predictor (2p = .014). As seen in Table 2, for these models
the F statistic was diminished, indicating that the association of NMUPD with future
delinquency was partially explained by these covariates. Within the violence exposure model,
violence exposure was a significant predictor, with more violence exposure predicting more
drug-related delinquency. Additionally, in the other drug use model, lifetime alcohol use was a
significant predictor; as alcohol use increased so did drug-related delinquency. In the mental
health model, NMUPD was no longer significant, suggesting that NMUPD does not account for
drug-related delinquency above and beyond mental health problems.
[INSERT TABLE 2 ABOUT HERE]
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3.3.2. Non-aggressive delinquency. As seen in Table 3, NMUPD group membership
significantly predicted future non-aggressive delinquency; demographic, violence exposure,
mental health, other drug use, and delinquency history covariates also were significant in these
models (2p ranged from .03 to .01). In the violence exposure model, violence exposure
significantly predicted and was positively associated with non-aggressive delinquency. In the
mental health model, increased alcohol dependency severity also predicted more non-aggressive
delinquency. In the other drug use model, being older, more lifetime alcohol use, and more
lifetime illicit drug use were significant predictors of increased non-aggressive delinquency.
However, in this model lifetime alcohol use (2p = .012) was a stronger predictor of delinquency
than NUMPD (2p = .011). In the delinquency history model, being older, more past nonaggressive delinquency, and more past aggressive delinquency predicted increases in future nonaggressive delinquency.
[INSERT TABLE 3 ABOUT HERE]
3.3.3. Aggressive delinquency. NMUPD group membership significantly predicted
future aggressive delinquency in the demographic, violence exposure, mental health, other drug
use, and delinquency history models with medium to small effect sizes, and explained more
variance than the covariates in these models (2p ranged from .06 to .01), as seen in Table 4. As
before, the association between NMUPD membership and aggressive delinquency was
attenuated once covariates were added to the model. In all models, males and older youth were
more likely to report aggressive delinquency. Additionally, in the violence exposure model,
violence exposure was a significant predictor of aggressive delinquency (2p = .118), and
stronger than NMUPD (2p = .022). Further in the mental health model, MDD severity, alcohol
dependency severity, drug abuse severity, and drug dependency severity were additional
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significant predictors of aggressive delinquency. In the other drug use model, lifetime alcohol
use was a significant predictor (2p = .031), and stronger than NMUPD (2p = .012). In the
delinquency history model, previous aggressive delinquency was the strongest predictor (2p =
.102).
[INSERT TABLE 4 ABOUT HERE]
3.3.4. Paired contrast tests. Paired contrast tests revealed that there were significant
group differences across all types of delinquency between youth who never engaged in NMUPD
and current users when the F statistic was significant. Further, there were significant differences
between youth who endorsed NMUPD at least once in their lifetime and current NMUPD users
across all models with significant F statistics. Finally, in the demographic and mental health
models with aggressive delinquency as the outcome, there was a significant group difference
between adolescent offenders who never used NMUPD and those who used NMUPD at least
once in their lifetime.
3.3.5. Final Models. As seen in Table 5, in all final models NMUPD was no longer
significant after accounting for the significant covariates related to each type of delinquency. A
history of more previous drug-related delinquency was the only significant predictor of future
drug-related delinquency after accounting for all other significant covariates. Being older and
involved in more non-aggressive delinquency were significant predictors of future nonaggressive delinquency, with age as the strongest predictor (2p = .006). Finally, being male and
older, and experiencing more violence exposure, lifetime alcohol use, and previous aggressive
delinquency were significant predictors of future aggressive delinquency. The strongest predictor
was previous aggressive delinquency (2p = .072).
[INSERT TABLE 5 ABOUT HERE]
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4. Discussion
The purpose of the present study was to examine the characteristics of NMUPD users
among serious adolescent offenders and to evaluate the unique contribution of their NMUPD
patterns in predicting future drug-related, non-aggressive, and aggressive delinquency. The
unique contribution of NMUPD use patterns in predicting future delinquency, over and above
known correlates of delinquency such as demographic characteristics, violence exposure, mental
health diagnoses, other drug use, and delinquency history was studied. Youth with varying
histories of NMUPD use (those who never used, used but not recently or frequently, and used
recently and frequently) differed at baseline on race/ethnicity, age, gender, both forms of
violence exposure, lifetime and recent mental health diagnoses, use of other drugs, and previous
delinquency history. Moreover, with the exception of the final set of models, NMUPD was a
significant predictor for the three distinct types of delinquency studied.
4.1. NMUPD among Serious Adolescent Offenders
Our findings indicated that adolescent offenders who reported engaging in NMUPD
either currently or at some point in their lives were mostly males, White or Hispanic, and tended
to be older than adolescent offenders who reported never engaging in NMUPD. These findings
are consistent with previous research in the general population indicating less reports of NMUPD
among Black youth (McCabe et al., 2012; McCauley et al., 2010; SAMHSA, 2013b; Young et
al., 2012) and younger adolescents (SAMHSA, 2013b; Young et al., 2012). Furthermore,
Hispanics were overrepresented in the “used NMPUD at least once in a lifetime” group; this
corresponds with recent findings among 7th and 12th graders in the general population where
Hispanic youth were more likely than their Black and white peers to report lifetime NMUPD
(King, Vidourek, & Merianos, 2013).
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While we observed more males reporting NMUPD than females, it is hard to interpret
these results since we also observed more males reporting never engaging in NMUPD. We
believe that these findings reflect the overrepresentation of males in all NMUPD groups in our
sample, rather than a gender effect on the use of NMUPD. That being said, and based on the
known association between mental health problems, other drug use and NMUPD (Catalano et al.,
2011; McCabe et al., 2012; McCauley et al., 2010), the reported higher rates of NMUPD among
female adolescents in the general population (Califano,2005; McCauley et al., 2010) and a higher
reported frequency of mental health problems among female offenders over their male
counterparts (Cauffman, 2008), we believe that female adolescent offenders may present more
NMUPD use than male adolescent offenders. This may be especially true when considering that,
in the overall sample, female adolescents met criteria for both mood/anxiety and substance use
disorders in higher proportions than did males (Mulvey & Schubert, 2012).
In terms of violence exposure, adolescent offenders who engaged in NMUPD reported
witnessing violence and experiencing more instances of direct victimization than adolescent
offenders who have never engaged in NMUPD. Moreover, youth who reported current NMUPD
had a higher proportion of lifetime, past year, and past 30 days mental health diagnoses when
compared with both youth who had used prescription drugs non-medically at least once in their
lifetime but not recently, and youth who had never engaged in NMUPD. These findings are
consistent with previous reports of the linkages between NMUPD use among the general
population and a history of violence exposure, PTSD, and MDD (Catalano, White, Fleming, &
Haggerty, 2011; McCauley et al., 2010; Schepis & Krishnan-Sarin, 2008).
Lastly, a similar pattern was observed in the reports of delinquent history and use of
alcohol, marijuana, and illicit drugs during their lifetime and past six months. Overall, higher
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instances of delinquent history and other drug use were reported by current NMUPD users,
followed by adolescent offenders who used NMUPD at least once in their lifetime, with
offenders who had never engaged in NMUPD having the fewest reports of delinquent history and
other drug use. Once again these findings are consistent with previously reported associations
between other drug use and increased levels of NMUPD among the general population (Boyd et
al., 2009; Catalano et al., 2011; Ford, 2008; McCabe et al., 2012; Schepis & Krishnan-Sarin,
2008; SAMHSA, 2013b; Wu et al., 2006; Young et al., 2012) and the strong associations
between drug use and delinquency (Adams et al., 2013; Barnes, Welte, & Hoffman, 2002;
Doran, Luczak, Bekman, Koutsenok, & Brown, 2012; Ford, 2008; Mason & Windle, 2002).
Overall, a general linear pattern was observed in the data. As adolescent offenders
reported more NMUPD use they also reported more violence exposure, mental health disorders,
other drug use, and delinquency history at baseline. These findings corroborate reported
associations between NMUPD, history of trauma, and other drug use among adolescent
offenders (Alemagno, Stephens, Shaffer-King, & Teasdale, 2009; Shook et al., 2011) and
advance our understanding of the characteristics of NMUPD users among serious juvenile
offenders, indicating that significant differences exist depending on the severity of NMUPD.
4.2. NMUPD and Future Delinquency
The findings in the present study support the contribution of NMUPD in predicting drugrelated, non-aggressive, and aggressive delinquency among serious adolescent offenders beyond
other known correlates of delinquency, with distinct differences for each type of delinquency. To
start, when looking at each model individually we observed that overall NMUPD was a
significant predictor of future drug-related delinquency. As we controlled for other variables in
our analyses, NMUPD remained a significant predictor of future drug-related delinquency,
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although the strength of the relationship was diminished. The exception to this pattern concerned
the mental health model where NMUPD was no longer associated with drug-related delinquency
after accounting for mental health problems. Furthermore, when demographics and all previously
significant variables where included (i.e., total violence exposure, drug abuse severity, lifetime
alcohol use, and drug-related delinquency history), NMUPD no longer was a significant
predictor of future drug-related delinquency.
Next, a similar pattern to the one described above was observed when the role of
NMUPD in predicting non-aggressive delinquency was examined. Once again we observed that
NMUPD group membership significantly predicted future non-aggressive delinquency while
controlling for demographic characteristics, violence exposure, mental health, other drug use,
and delinquency history, with a diminishing pattern in the strength of the relationship as different
variables were considered. Furthermore, when the demographic and previously significant
variables where included (i.e., total violence exposure, alcohol dependency severity, lifetime
alcohol use, lifetime illicit drug use, non-aggressive delinquency history, and aggressive
delinquency history), NMUPD group membership no longer was a significant predictor of future
non-aggressive delinquency. Specifically being older and having engaged in more nonaggressive delinquency in the past significantly predicted future non-aggressive delinquency.
Additionally, NMUPD group membership was a significant predictor of future aggressive
delinquency in the demographic, violence exposure, mental health, other drug use, and
delinquency history models, with indication of its variance explained by the addition of other
variables just as with drug related delinquency and non-aggressive delinquency. When all
demographics and previously significant variables (i.e., total violence exposure, MDD severity,
alcohol dependency severity, drug abuse severity, drug dependency severity, lifetime alcohol

NMUPD IN ADOLESCENT OFFENDERS

25

use, and aggressive delinquency history) were included in the final model, NMUPD group
membership no longer was a significant predictor of future aggressive delinquency. These results
suggest that youth who engage in aggressive delinquency may have a more complex history that
explains future aggressive delinquency as compared to those youth who engage in drug-related
or non-aggressive delinquency. When the significant predictors are examined in terms of
importance previous aggressive delinquency explains most of the variance, followed by total
violence exposure, age, sex, then lifetime alcohol use. Similar to other findings, there appears to
be a stronger connection between violence exposure and self-reported aggressive delinquency as
compared to other forms of delinquency (Lansford et al., 2007). Also, within this unique
population older male youth appear to be at most risk, which is similar to general populations in
previous research (SAMHSA, 2013b). Finally, lifetime alcohol use appears to be more important
in aggressive delinquency as compared to other types of delinquency, as well as more important
than NMUPD. This may be because alcohol is still one of the most easily accessible substances
for adolescents to attain (National Center on Addiction and Substance Abuse at Columbia
University (CASA), 2012). However, with the increasing availability of prescription drugs, and
research which suggests that youth perceive taking prescription drugs recreationally to be more
safe than using other illicit substances (Arria, Caldeira, Vincent, O’Grady, & Wish, 2008;
Inciardi, Surratt, Kurtz, & Cicero, 2007; Mui, Sales, & Murphy, 2013), this finding may change
in future years if proper interventions are not enacted.
It is noteworthy that previous history of a specific type of delinquency consistently was a
significant predictor for its future occurrence; previous drug-related delinquency predicted future
drug-related delinquency, previous non-aggressive delinquency predicted future non-aggressive
delinquency, and previous aggressive delinquency predicted future aggressive delinquency. In all
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except non-aggressive delinquency prior offending history was the strongest predictor of future
delinquency. These findings correspond to prior reported associations between delinquency
history and recidivism (Lipsey & Derzon, 1998; Stouthamer-Loeber et al., 2004) and again
highlight the urgent need to develop pathways to desistance. Moreover, the importance of
violence exposure, other drug use and mental health problems was evident. Specifically abuse
and dependency on alcohol and drugs, as well as MDD severity need to be considered when
conducting research and practice with adolescent offenders. Lastly, a history of violence
exposure seemed to impact adolescent offenders across all types of offenses, highlighting the
important role of contextual factors in prevention efforts. These findings emphasize the need to
consider a variety of risk factors when examining delinquency. The findings also provide
evidence that it is important to consider the pattern of delinquency, as different predictors
emerged depending on which type of delinquency the adolescent offender reported. Also, it is
important to consider which variables are being considered when investigating NMUPD as the
importance of NMUPD differed depending on which covariates were included in the model.
Without considering all of the significant variables researchers may not fully understand the
relative important of NMUPD in future delinquency.
Finally, severity of NMUPD matters in predicting future types of offenses; as evidenced
by our findings. There were significant group differences across all types of delinquency
between adolescent offenders who engaged in current NMUPD and those who never engaged in
NMUPD. In addition, there were significant differences between youth who engaged in current
NMUPD and those who endorsed NMUPD at least once in their lifetime. These findings
supported the unique contribution of NMUPD in predicting future delinquency among
adolescent offenders, and point out the important task ahead in terms of prevention efforts. The
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results also indicate the need to assess and intervene for multiple risk factors as there were a
variety of predictors found to be important in resulting delinquency in this at-risk population.
4.3. Limitations
While the study had many strengths, it is important to note limitations that may have
impacted the results. First, this study may not adequately represent gender differences between
groups of NMUPD users among adolescent offenders, nor gender influence in predicting future
offenses due to the overrepresentation of males in our sample. Further, males involved in drugrelated offenses were capped, so the current sample may not be representative for all youth
involved in drug-related delinquency. It is also possible that the predictors investigated were
moderated by gender; this should be investigated in future studies. Additionally, due to restricted
access to variables regarding violent offenses, we used the “aggressive offending scale” created
by the authors of the parent study. This meant that some offenses with an arguably nonaggressive connotation, such as property damage, were included in the analyses. Concurrent
alcohol and other drug use were also not controlled for in all models as the authors were
interested in the unique prediction of NMUPD. However, given the previous literature on
polydrug use and the results of this study, future research should continue to investigate how
NMUPD interacts with alcohol and other drug use which may predict delinquency. Finally, this
study relied solely on adolescent self-reports which raises concerns of shared method variance
and socially desirable responding (Kazdin, 2003). Nevertheless, the results suggest different
characteristics of NMUPD users among adolescent offenders and an important role of NMUPD
severity in the prediction of future delinquency.
4.4. Implications
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The present study significantly contributes to the understanding of NMUPD among
adolescent offenders in several ways. As far as we know, this is the first study to specify the
characteristics of NMUPD among adolescent offenders and to examine its relation with drugrelated, non-aggressive, and aggressive delinquency separately. Thus, several important
implications for prevention and intervention efforts follow from the present study. First, a better
understanding of the differences among adolescent offenders who engage in NMUPD and those
who do not is needed in order to determine best approaches for treatment and intervention.
Consequently, practitioners and researchers interested in promoting pathways to desistance
would benefit from a better understanding of the findings reported, and from the identification of
potential moderating factors both at the protective and risk levels, which allow for the design and
implementation of prevention and treatment efforts that address those factors susceptible of
change. Likewise, as previously noted by others (Alemagno, Stephens, Shaffer-King, &
Teasdale, 2009; King, Vidourek, & Merianos, 2013), it is also important to understand both
individual and contextual factors associated to the increasing rate of NMUPD among the general
population and among adolescent offenders to inform prevention efforts. For example, an
individual’s personality and preferred coping styles as well as parental drug or alcohol problems
and an association with deviant peers, among others, may be influencing some of the
associations here reported. Finally, education initiatives to promote awareness among adolescent
offenders of the potential psychological and physical dangers that are associated with NMUPD
use are needed. Previous research supports the use of educational strategies to reduce substance
use among adolescents (Tolan, Szapocznik, & Sambrano, 2007) and these efforts also might be
successfully replicated for adolescent offenders.
4.5. Conclusion
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NMUPD is an increasing and significant public health problem that warrants the attention
of policy makers, researchers, and practitioners. The concern regarding NMUPD for the general
population and adolescent offenders is well founded, especially when taking into account that the
use of NMUPD in the general population has become more prevalent than the use of other illicit
drugs, with the exception of marijuana (Novak, Calvin, Glasheen, & Edlund, 2011; SAMHSA,
2013b). Adolescent offenders are a group with a particularly elevated risk of engaging in both
substance use and continued delinquency, hence the urgent need to identify potential factors that
may prevent desistance, such as NMUPD and the mechanism by which said factors operate.
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Table 1
NMUPD group differences in baseline demographic factors and correlates of delinquency (N =
1,349)
Group 2

Characteristic:

Group 1

Used

Group 3

Never Used

NMUPD in

Current NMUPD

NMUPD

Lifetime

Users

(n = 944)

(n = 258)

(n = 147)

Univariate Test of
Difference

Demographic Factors
2(6) = 100.93***

Race/Ethnicity
White [% (n)]

14.6 (138)

30.6 (79)

38.8 (57)

Black [% (n)]

48.5 (458)

27.9 (72)

17.7 (26)

Hispanic [% (n)]

32.6 (308)

34.5 (89)

38.8 (57)

Other [% (n)]

4.3 (40)

7.0 (18)

4.7 (7)

Sex [% Male (n)]

88.6 (836)

83.3 (215)

77.6 (114)

2(2) = 15.57***

Mean Age (SD)a,b

15.93 (1.15)

16.36 (1.12)

16.21 (1.01)

F(2, 1346) = 17.04***

Mean SES (SD)

51.83 (12.63) 51.20 (11.87) 49.23 (10.71)

F(2, 1338) = 2.89

0.45 (0.32)

0.50 (0.32)

0.45 (0.32)

F(2, 1167) = 2.63

3.51 (1.95)

4.27 (1.89)

4.63 (1.64)

F(2,1346) = 32.61***

(SD)a,b,c

1.27 (1.34)

2.09 (1.45)

2.63 (1.48)

F(2,1346) = 83.51***

Total Score Mean (SD)a,b,c

4.78 (2.85)

6.36 (2.92)

7.25 (2.77)

F(2,1346) = 67.60***

Proportion of time with no
community access mean (SD)
Violence Exposure
Witnessed Violence Mean (SD)a,b
Directly Victimized Mean
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Group 2

Group 3

Group 1

Used

Current

Never Used

NMUPD in

NMUPD

NMUPD

Lifetime

Users

(n = 944)

(n = 258)

(n = 147)

Univariate Test of
Difference

Mental Health
Lifetime
Major depressive disorder
[% Yes (n)]

5.2 (48)

9.4 (24)

17.6 (25)

2(2) = 30.22***

PTSD [% Yes (n)]

4.3 (40)

9.8 (25)

14.8 (21)

2(2) = 28.11***

Alcohol abuse [% Yes (n)]

8.3 (76)

14.9 (37)

25.0 (35)

2(2) = 37.21***

[% Yes (n)]

4.2 (38)

21.0 (52)

30.0 (42)

2(2) = 128.07***

Drug abuse [% Yes (n)]

21.3 (194)

34.3 (85)

45.7 (64)

2(2) = 47.15***

Drug dependency [% Yes (n)]

7.6 (69)

30.6 (76)

42.1 (59)

2(2) = 161.47***

[% Yes (n)]

3.7 (34)

8.2 (21)

10.6 (15)

2(2) = 17.30***

PTSD [% Yes (n)]

2.5 (23)

5.1 (13)

11.3 (16)

2(2) = 26.47***

Alcohol abuse [% Yes (n)]

6.4 (58)

8.1 (20)

20.0 (28)

2(2) = 30.16***

[% Yes (n)]

3.1 (28)

14.1 (35)

24.3 (34)

2(2) = 98.75***

Drug abuse [% Yes (n)]

15.6 (142)

21.4 (53)

39.3 (55)

2(2) = 44.85***

Drug dependency [% Yes (n)]

6.0 (55)

21.4 (53)

40.7 (57)

2(2) = 152.58***

Alcohol dependency

Past Year
Major depressive disorder

Alcohol dependency
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Group 2

Group 3

Group 1

Used

Current

Never Used

NMUPD in

NMUPD

NMUPD

Lifetime

Users

(n = 944)

(n = 258)

(n = 147)

Univariate Test of
Difference

Past 30 Days
Major depressive disorder
[% Yes (n)]

1.0 (14)

2.7 (7)

2.8 (4)

2(2) = 6.10*

PTSD [% Yes (n)]

1.6 (15)

3.9 (10)

5.6 (8)

2(2) = 10.89**

Alcohol abuse [% Yes (n)]

0.3 (3)

1.2 (3)

2.9 (4)

2(2) = 10.94**

0.2 (2)

0.8 (2)

0.5 (7)

2(2) = 8.80*

Drug abuse [% Yes (n)]

1.9 (17)

2.4 (6)

7.1 (10)

2(2) = 13.69**

Drug dependency [% Yes (n)]

0.5 (5)

1.6 (4)

9.3 (13)

2(2) = 55.71***

Alcohol use mean (SD)a,b,c

3.76 (2.55)

5.81 (2.48)

6.50 (2.50)

F(2, 1346) = 120.67***

Marijuana use mean (SD)a,b

5.60 (3.35)

8.08 (2.01)

8.76 (0.98)

F(2, 1346) = 122.56***

Illicit drug use mean (SD)a,b,c

0.74 (2.21)

5.19 (5.46)

9.50 (7.29)

F(2,1346) = 403.26***

Alcohol use mean (SD)a,b,c

2.47 (2.17)

3.31 (2.56)

4.86 (2.74)

F(2,1345) = 120.67***

Marijuana use mean (SD)a,b,c

3.59 (3.23)

4.48 (3.44)

7.48 (2.46)

F(2,1345) = 95.42***

Illicit drug use mean (SD)a,b,c

0.34 (1.47)

1.43 (2.95)

5.79 (5.70)

F(2,1346) = 284.29***

Alcohol dependency [% Yes
(n)]

Other Drug Use
Lifetime

Past 6 Months
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Group 2

Group 3

Group 1

Used

Current

Never Used

NMUPD in

NMUPD

NMUPD

Lifetime

Users

(n = 944)

(n = 258)

(n = 147)

0.32 (0.36)

0.65 (0.37)

0.77 (0.33)

F(2,1343) = 154.58***

0.28 (0.22)

0.48 (0.22)

0.57 (0.22)

F(2,1342) =98.31***

0.26 (0.18)

0.37 (0.21)

0.44 (0.23)

F(2,1343) = 76.05***

0.33 (0.32)

0.30 (0.36)

0.60 (0.36)

F(2,841) = 39.11***

0.15 (0.17)

0.16 (0.19)

0.37 (0.24)

F(2,1123) =55.17***

0.11 (0.13)

0.14 (0.13)

0.24 (0.20)

F(2,1343) = 53.91***

Univariate Test of
Difference

Delinquency History Severity
Index
Lifetime
Drug delinquency mean (SD)a,b,c
Non-aggressive delinquency
mean (SD)a,b,c
Aggressive delinquency
mean (SD)a,b,c
Past 6 Months
Drug delinquency mean (SD)b,c
Non- aggressive delinquency
mean (SD)a,b,c
Aggressive delinquency
mean (SD)a,b,c

Note. Values are N (unweighted) and % (weighted) unless otherwise specified. NMUPD = Nonmedical use of prescription drugs, PTSD = Post traumatic stress disorder.
*

p < .05.**p < .01.***p < .001.
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a

Significant difference (p < .05) between Group 1 and Group 2

b

Significant difference (p< .05) between Group 1 and Group 3

c

Significant difference (p< .05) between Group 2 and Group 3
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Table 2
ANCOVA Models for NMUPD Predicting Future Drug-Related Delinquency in Adolescent Offenders
Category

Model 1:

Model 2:

Model 3:

Model 4:

Model 5:

Demographic

Violence Exposure

Mental Health

Other Drug Use

Delinquency History

F

df

2p

df

2p

F

df

2p

F

df

2p

1,1033 .000

0.01

1,1032

.000 0.71

1,993

.001

0.26

1,1030

.000

0.00

1,1028

.000

2.07

1,1033 .002

0.79

1,1032

.001 1.92

1,993

.002

1.64

1,1030

.002

0.13

1,1028

.000

Age

0.08

1,1033 .000

0.05

1,1032

.000 0.01

1,993

.000

0.23

1,1030

.000

0.72

1,1028

.001

SES

2.65

1,1033 .003

2.21

1,1032

.002 4.49*

1,993

.005

3.38

1,1030

.003

2.62

1,1028

.003

Proportion of time

0.00

1,1033 .000

0.14

1,1032

.000 0.02

1,993

.000

0.08

1,1030

.000

0.44

1,1028

.000

F

df

Race/Ethnicity

0.29

Sex

2p

F

Demographic
factors

with no community
access

Violence Exposure
Total violence
exposure

13.89*** 1,1032

.013
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Model 1:

Model 2:

Model 3:

Model 4:

Model 5:

Demographic

Violence Exposure

Mental Health

Other Drug Use

Delinquency History

F

df

2p

MDD

3.05

1,993

.003

PTSD

0.56

1,993

.001

Alcohol abuse

0.35

1,993

.000

Alcohol

3.76

1,993

.004

Drug abuse

7.67** 1,993

.008

Drug dependency

2.40

.002

F

df

2p

F

df

2p

F

df

2p

5.63*

1,1030

.005

3.10

1,1030

.003

0.02

1,1030

.000

Mental health
severity

dependency

1,993

Other drug use
Lifetime alcohol
use
Lifetime marijuana
use
Lifetime illicit drug
use

F

df

2p

NMUPD IN ADOLESCENT OFFENDERS

Category

46

Model 1:

Model 2:

Model 3:

Model 4:

Model 5:

Demographic

Violence Exposure

Mental Health

Other Drug Use

Delinquency History

F

df

2p

F

df

2p

F

df

2p

F

df

2p

F

df

2p

Delinquency
history
Drug-related

14.11*** 1,1028

.014

Non-aggressive

0.10

1,1028

.000

Aggressive

2.98

1,1028

.003

15.76*** 2,1033 .030 9.56*** 2,1032 .018 2.74
2,993 .005 6.09** 2,1030 .012 4.99**
2,1028
Note. MDD = Major depressive disorder, NMUPD = Non-medical use of prescription drugs, PTSD = Post traumatic stress disorder,

.010

NMUPD Group

a,b

a,b

a,b

SES = Socioeconomic status.
*

p < .05. ** p < .01. *** p < .001.

a

Significant difference (p < .05) between Group 1: Never Used NMUPD and Group 3: Current NMUPD Users

b

Significant difference (p < .05) between Group : Used NMUPD in Lifetime 2 and Group 3: Current NMUPD Users

a,b
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Table 3
ANCOVA Models for NMUPD Predicting Future Non-Aggressive Delinquency in Adolescent Offenders
Category

Model 1:

Model 2:

Model 3:

Model 4:

Model 5:

Demographic

Violence Exposure

Mental Health

Other Drug Use

Delinquency History

df

2p

F

df

1,1033 .001 1.91

1,1032

.001

0.18

2.11

1,1033 .002 0.97

1,1032

.001

2.36

1,1033 .002 3.84

1,1032

0.91

1,1033 .001 0.68

Proportion of time 0.13

1,1033 .000 0.00

F

df

0.71

2p

F

2p

F

df

2p

F

df

2p

1,993 .000

0.09

1,1030

.000

0.98

1,1028

.001

1.91

1,993 .002

1.50

1,1030

.001

0.05

1,1028

.000

.004

3.28

1,993 .003

5.18*

1,1030

.005

4.79*

1,1028

.005

1,1032

.001

1.27

1,993 .001

1.96

1,1030

.002

1.36

1,1028

.001

1,1032

.000

0.17

1,993 .000

0.03

1,1030

.000

0.04

1,1028

.000

1,1032

.010

Demographic
factors
Race/Ethnicity
Sex
Age
SES

with no
community access

Violence
Exposure
Total violence
exposure

9.99**
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Model 1:

Model 2:

Model 3:

Model 4:

Model 5:

Demographic

Violence Exposure

Mental Health

Other Drug Use

Delinquency History

F

df

2p

F

df

2p

2p

F

df

MDD

0.62

1,993 .001

PTSD

0.79

1,993 .001

Alcohol abuse

0.66

1,993 .001

Alcohol

7.91** 1,993 .008

F

df

2p

Mental health
severity

dependency
Drug abuse

0.02

1,993 .000

Drug dependency

0.02

1,993 .006

Other drug use
Lifetime alcohol

12.90*** 1,1030

.012

0.01

1,1030

.000

3.91*

1,1030

.004

use
Lifetime
marijuana use
Lifetime illicit
drug use

F

df

2p
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Model 1:

Model 2:

Model 3:

Model 4:

Model 5:

Demographic

Violence Exposure

Mental Health

Other Drug Use

Delinquency History

F

df

2p

F

df

2p

F

df

2p

F

df

2p

F

df

2p

0.52

1,1028

.001

6.28*

1,1028

.006

5.63*

1,1028

.005

7.05** 2,1028

.014

Delinquency
history
Drug-related
Non-aggressive
Aggressive

NMUPD Group

a,b

a,b

a,b

a,b

17.90*** 2,1033 .033 12.23*** 2,1032 .023 3.91* 2,993 .008 5.57**
2,1030 .011
Note. MDD = Major depressive disorder, PTSD = Post traumatic stress disorder, SES = Socioeconomic status.
*

p < .05. ** p < .01. *** p < .001.

a

Significant difference (p < .05) between Group 1: Never Used NMUPD and Group 3: Current NMUPD Users

b

Significant difference (p < .05) between Group : Used NMUPD in Lifetime 2 and Group 3: Current NMUPD Users

a,b
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Table 4
ANCOVA Models for NMUPD Predicting Future Aggressive Delinquency in Adolescent Offenders
Category

Model 1:

Model 2:

Model 3:

Model 4:

Model 5:

Demographic

Violence Exposure

Mental Health

Other Drug Use

Delinquency History

2p

F

df

2p

2p

F

df

F

df

0.41

1,1033 .000 1.53

1.05

1,993 .001

32.85***

1,1033 .029 18.44*** 1,1032 .016

28.93*** 1,993 .026

6.48*

1,1033 .006 18.59*** 1,1032 .016

8.01**

1.62

1,1033 .001 3.04

1,1032 .003

1.70

1,1033 .002 0.05

1,1032 .000

2p

F

df

1.46

1,1030 .001

2p

F

df

0.27

1,1028 .000

31.39*** 1,1030 .028

11.41**

1,1028 .010

1,993 .007

16.15*** 1,1030 .014

14.21*** 1,1028 .013

1.14

1,993 .001

0.53

1,1030 .000

1.68

1,1028 .002

1.47

1,993 .001

0.76

1,1030 .001

0.01

1,1028 .000

Demographic
factors
Race/Ethnicity
Sex
Age
SES
Proportion of time

1,1032 .001

with no community
access

Violence
Exposure
Total violence
exposure

147.93*** 1,1032 .118
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Model 1:

Model 2:

Model 3:

Model 4:

Model 5:

Demographic

Violence Exposure

Mental Health

Other Drug Use

Delinquency History

F

df

2p

F

df

2p

2p

F

df

MDD

4.84*

1,993 .004

PTSD

1.15

1,993 .001

Alcohol abuse

3.41

1,993 .003

Alcohol

7.33**

1,993 .007

Drug abuse

5.40*

1,993 .007

Drug dependency

10.07**

1,993 .009

F

df

2p

Mental health
severity

dependency

Other drug use
Lifetime alcohol

35.33*** 1,1030 .031

use
Lifetime marijuana

3.70

1,1030 .003

3.48

1,1030 .003

use
Lifetime illicit drug
use

F

df

2p
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Model 1:

Model 2:

Model 3:

Model 4:

Model 5:

Demographic

Violence Exposure

Mental Health

Other Drug Use

Delinquency History

F

df

2p

F

df

2p

F

df

2p

F

df

2p

2p

F

df

0.19

1,1028 .000

0.51

1,1028 .000

Delinquency
history
Drug-related
Non-aggressive

125.46*** 1,1028 .102

Aggressive

NMUPD Group

a,b,c

b,c

a,b,c

b,c

35.42*** 2,1033 .060 12.32*** 2,1032 .022 8.42*** 2,993 .015 6.46**
2,1030 .012
Note. MDD = Major depressive disorder, PTSD = Post traumatic stress disorder, SES = Socioeconomic status.
*

p < .05. ** p < .01. *** p < .001.

a

Significant difference (p < .05) between Group 1: Never Used NMUPD and Group 2: Used NMUPD in Lifetime

b

Significant difference (p < .05) between Group 1: Never Used NMUPD and Group 3: Current NMUPD Users

c

Significant difference (p < .05) between Group : Used NMUPD in Lifetime 2 and Group 3: Current NMUPD Users

b,c

1.06**

2,1028 .013
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Table 5
Final ANCOVA Models for NMUPD Predicting Future Delinquency in Adolescent Offenders
F

df

p

2p

Race/Ethnicity

0.05

1,993

.827

.000

Sex

0.23

1,993

.635

.000

Age

1.07

1,993

.301

.001

SES

3.75

1,993

.053

.004

Proportion of time with no community access

0.40

1,993

.530

.000

Total violence exposure

3.11

1,993

.078

.003

Drug abuse severity

1.61

1,993

.205

.002

Lifetime alcohol use

2.18

1,993

.140

.002

Drug-related delinquency history

12.13

1,993

.001

.012

NMUPD

2.07

2, 993

.127

.004

Race/Ethnicity

0.09

1,991

.764

.000

Sex

0.11

1,991

.683

.000

Age

5.54

1,991

.019

.006

SES

2.27

1,991

.141

.002

Proportion of time with no community access

0.08

1,991

.928

.000

Total violence exposure

0.11

1,991

.745

.000

Alcohol dependencyseverity

2.21

1,991

.137

.002

Lifetime alcohol use

2.96

1,991

.086

.003

Lifetime illicit drug use

1.72

1,991

.190

.002

Non-aggressive delinquency history

5.13

1,991

.024

.005

Aggressive delinquency history

2.89

1,991

.089

.003

NMUPD

1.85

2, 991

.158

.004

Final Models
Drug-related delinquency

Non-aggressive delinquency

NMUPD IN ADOLESCENT OFFENDERS

54
F

df

p

2p

Race/Ethnicity

0.64

1,1068

.423

.001

Sex

10.77

1,1068

.001

.010

Age

20.74

1,1068

< .001 .019

SES

1.72

1,1068

.190

.002

Proportion of time with no community access

0.13

1,1068

.716

.000

Total violence exposure

24.53

1,1068

< .001 .022

MDD severity

1.42

1,1068

.233

.001

Alcohol dependency severity

0.95

1,1068

.331

.001

Drug abuse severity

0.02

1,1068

.897

.000

Drug dependency severity

0.88

1,1068

.348

.001

Lifetime alcohol use

8.95

1,1068

.003

.008

Aggressive delinquency history

82.41

1,1068

< .001 .072

NMUPD

1.82

2,1068

.162

Final Models
Aggressive delinquency

.003

Note. MDD = Major depressive disorder, NMUPD = Non-medical use of prescription drugs,
SES = Socioeconomic status.

